Corporate Strategy
Strategy is about making the hard choices that give your company the focus necessary to achieve a sustainable competitive advantage.
Operating at the intersection of science, technology, and business strategy, Health Advances helps companies make decisions that drive successful business outcomes. We have worked with over 1,000 companies and investors on over 3,500 assignments, across the entire spectrum of strategic questions, providing fresh perspectives, relevant knowledge, and actionable insights.
Strategy is about making the hard choices that give your company the focus necessary to achieve a sustainable competitive advantage.
Successful commercialization hinges on thoughtful prioritization and sharp strategy to translate innovation into value.
New health technologies most often miss revenue expectations when there is not a clear understanding of stakeholder buying processes, reimbursement and business models, and ideal customer profiles. To successfully commercialize a new technology, you need a strategic partner that understands the intricacies of your market and product and is dedicated to delivering greater value globally.
While innovation in healthcare is skyrocketing, payers are more pressured than ever to save costs. These constraints are leading to increasing scrutiny on evidence pre-and post-launch, new cost containment measures and pricing policies, and evolving HTA, reimbursement pathways and payment models.
Considerations of value and access need to be integrated early and throughout trials and the product lifecycle to avoid significant loss of commercial potential.
Take due diligence deeper with data-driven, rigorously quantified assessments that help you gain a realistic picture from a trusted partner, spot synergies others miss, and prepare to drive upside long before the deal is finalized.
Effective BD requires a strategy to prioritize growth opportunities that leverage right-to-win, fit strategically, and optimize the value of your portfolio.